Priority Applications (10) Applications Claiming Priority (1) Publications (1) Family ID=44508594 Family Applications (2) Family Applications After (1) Country Status (8) Cited By (1) Families Citing this family (1) Citations (6) Family Cites Families (1) 2011 2011-07-27 EP EP11006163A patent/EP2551350A1/en not_active Ceased 2012 2012-07-25 WO PCT/EP2012/064575 patent/WO2013014179A1/en not_active Ceased 2012-07-25 TW TW101126708A patent/TWI595093B/en not_active IP Right Cessation 2012-07-25 EP EP12738462.6A patent/EP2737074B1/en active Active 2012-07-25 JP JP2014522074A patent/JP2014521325A/en active Pending 2012-07-25 US US13/557,922 patent/US9523106B2/en active Active 2012-07-25 KR KR1020147004878A patent/KR20140057286A/en not_active Ceased 2012-07-25 AR ARP120102701A patent/AR087317A1/en unknown 2012-07-25 CN CN201280036473.6A patent/CN103703138A/en active Pending 2017 2017-01-26 JP JP2017012180A patent/JP6169812B2/en not_active Expired - Fee Related
When feasible, the proximal isovelocity surface area (PISA) method is recommended to quantify the regurgitant volume and effective regurgitant orifice area (EROA) ( FIGURE 5 While 2D TTE is widely used as the principal technique to investigate MR severity, several limitations have to be addressed, which can originate from specific MR characteristics, such as orifice morphology, eccentric or multiple jets (Table 1)
Matye, D., Leak, J., Woolbright, B
It is used in both children and adults to determine the risk of cardiovascular diseases, such as heart disease, heart attacks, and strokes
J Basic Clin Pharm
Even though collagen contains proteins, it is not a replacement for protein powder
